GNLX
GENELUX Corp
NASDAQ · Healthcare · Biotechnology · US
$2.53
+0.00%Margins
Gross margin
-1762.5%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-209.7%
Return on equity
-129.0%
Return on assets
-192.2%
Return on invested capital
0.00x
Asset turnover
-$25.3M
Cash from operations
$0.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026